[PHARMA] QoQ Cumulative Quarter Result on 30-Sep-2018 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Nov-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
30-Sep-2018 [#3]
Profit Trend
QoQ- 65.5%
YoY- 18.76%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 1,387,998 786,108 2,384,956 1,788,312 1,200,652 617,923 2,323,960 -29.14%
PBT 42,724 30,243 70,220 58,280 40,677 28,707 73,064 -30.14%
Tax -13,814 -10,595 -26,990 -19,620 -17,322 -11,118 -17,977 -16.14%
NP 28,910 19,648 43,230 38,660 23,355 17,589 55,087 -35.01%
-
NP to SH 28,898 19,617 42,468 38,031 22,980 17,586 53,823 -34.01%
-
Tax Rate 32.33% 35.03% 38.44% 33.67% 42.58% 38.73% 24.60% -
Total Cost 1,359,088 766,460 2,341,726 1,749,652 1,177,297 600,334 2,268,873 -29.00%
-
Net Worth 518,564 528,825 509,862 522,618 519,642 524,838 526,888 -1.05%
Dividend
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Div 22,149 15,630 41,621 36,401 23,383 12,991 49,314 -41.43%
Div Payout % 76.65% 79.68% 98.01% 95.71% 101.76% 73.87% 91.62% -
Equity
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Net Worth 518,564 528,825 509,862 522,618 519,642 524,838 526,888 -1.05%
NOSH 261,229 260,505 260,505 260,505 259,821 259,821 259,821 0.36%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin 2.08% 2.50% 1.81% 2.16% 1.95% 2.85% 2.37% -
ROE 5.57% 3.71% 8.33% 7.28% 4.42% 3.35% 10.22% -
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
RPS 532.65 301.76 916.82 687.79 462.11 237.83 895.38 -29.33%
EPS 11.09 7.53 16.33 14.63 8.84 6.77 20.74 -34.19%
DPS 8.50 6.00 16.00 14.00 9.00 5.00 19.00 -41.59%
NAPS 1.99 2.03 1.96 2.01 2.00 2.02 2.03 -1.32%
Adjusted Per Share Value based on latest NOSH - 260,505
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
RPS 96.31 54.54 165.48 124.08 83.31 42.87 161.25 -29.14%
EPS 2.01 1.36 2.95 2.64 1.59 1.22 3.73 -33.85%
DPS 1.54 1.08 2.89 2.53 1.62 0.90 3.42 -41.33%
NAPS 0.3598 0.3669 0.3538 0.3626 0.3606 0.3642 0.3656 -1.06%
Price Multiplier on Financial Quarter End Date
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Date 28/06/19 29/03/19 31/12/18 28/09/18 29/06/18 30/03/18 29/12/17 -
Price 2.84 2.27 2.78 2.89 2.88 4.28 4.60 -
P/RPS 0.53 0.75 0.30 0.42 0.62 1.80 0.51 2.60%
P/EPS 25.61 30.14 17.03 19.76 32.56 63.23 22.18 10.08%
EY 3.90 3.32 5.87 5.06 3.07 1.58 4.51 -9.25%
DY 2.99 2.64 5.76 4.84 3.13 1.17 4.13 -19.42%
P/NAPS 1.43 1.12 1.42 1.44 1.44 2.12 2.27 -26.57%
Price Multiplier on Announcement Date
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Date 23/08/19 16/05/19 21/02/19 19/11/18 17/08/18 16/05/18 27/02/18 -
Price 2.66 2.36 2.76 3.09 3.11 4.07 4.04 -
P/RPS 0.50 0.78 0.30 0.45 0.67 1.71 0.45 7.29%
P/EPS 23.99 31.34 16.91 21.13 35.16 60.13 19.48 14.93%
EY 4.17 3.19 5.92 4.73 2.84 1.66 5.13 -12.93%
DY 3.20 2.54 5.80 4.53 2.89 1.23 4.70 -22.66%
P/NAPS 1.34 1.16 1.41 1.54 1.56 2.01 1.99 -23.23%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment